These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35390644)

  • 1. Selection of the appropriate avibactam concentration for use with ceftibuten in broth microdilution susceptibility testing.
    Sader HS; Lindley J; Deshpande LM; Doyle T; Castanheira M
    Diagn Microbiol Infect Dis; 2022 Jun; 103(2):115673. PubMed ID: 35390644
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Karlowsky JA; Hackel MA; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0134622. PubMed ID: 36602322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes.
    Mendes RE; Rhomberg PR; Watters AA; Castanheira M
    J Antimicrob Chemother; 2022 Feb; 77(3):689-694. PubMed ID: 34849977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021).
    Sader HS; Carvalhaes CG; Huband MD; Mendes RE; Castanheira M
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):453-459. PubMed ID: 36810724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of
    Karlowsky JA; Wise MG; Hackel MA; Pevear DC; Moeck G; Sahm DF
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0093422. PubMed ID: 36286518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
    Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Karlowsky JA; Hackel MA; Sahm DF
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0130421. PubMed ID: 34662183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019.
    Jean SS; Lee YL; Hsu CW; Hsueh PR
    Int J Antimicrob Agents; 2022 Sep; 60(3):106617. PubMed ID: 35718266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing.
    Bradford PA; Huband MD; Stone GG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing
    Bhatnagar A; Boyd S; Sabour S; Bodnar J; Nazarian E; Peinovich N; Wagner C; Craft B; Snippes Vagnone P; Simpson J; Stone VN; Therrien M; Bateman A; Lower D; Huang JY; Gumbis S; Lonsway D; Lutgring JD; Karlsson M; Brown AC
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0048621. PubMed ID: 34060895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
    Castanheira M; Sader HS; Farrell DJ; Mendes RE; Jones RN
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4779-85. PubMed ID: 22733066
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760124
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine.
    Giani T; Antonelli A; Sennati S; Di Pilato V; Chiarelli A; Cannatelli A; Gatsch C; Luzzaro F; Spanu T; Stefani S; Rossolini GM
    J Antimicrob Chemother; 2020 Apr; 75(4):979-983. PubMed ID: 31958125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales.
    Mushtaq S; Vickers A; Ellaby N; Woodford N; Livermore DM
    J Antimicrob Chemother; 2021 Dec; 77(1):98-111. PubMed ID: 34568905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales.
    Kelley CJ; Kennedy-Mendez A; Walser ON; Thwaites MT; Arhin FF; Pillar CM; Hufnagel DA
    Microbiol Spectr; 2022 Dec; 10(6):e0360122. PubMed ID: 36342288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.